课题基金 / 基金详情

Liver Fibrosis: Leveraging Novel Statistical Methods to Determine Optimal Screening Strategy for People Living with Type 2 Diabetes

Liver Fibrosis: Leveraging Novel Statistical Methods to Determine Optimal Screening Strategy for People Living with Type 2 Diabetes
肝纤维化：利用新的统计方法确定 2 型糖尿病患者的最佳筛查策略
批准号：
488421
负责人：
Saeed Sahar Z
金额：
$28.42万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-09-01 至 2028-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=488421&lang=en
关键词：
Adminstrative Data (Ices) Cirrhosis Liver Disease Maslf/Nafld Metabolic Disease Multistate Models Screening Type 2 Diabetes

项目摘要

项目成果

Saeed Sahar Z的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is caused by fat accumulating in the liver over time. Fat causes inflammation, which scares the liver (known as liver fibrosis) and puts patients at increased risk of many more severe liver
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Breaking Barriers: Expanding Syphilis Point-of-care Testing and Immediate Treatment to Meet the Needs of Underserved Communities
The 13th Canadian Symposium on Hepatitis C Virus (CSHCV)
Advancing Syphilis Elimination: Leveraging Public Health and Academic Partnerships to Build Capacity
Breaking Barriers: Expanding Syphilis Point-of-care Testing and Immediate Treatment to Meet the Needs of Underserved Communities
海外基金